Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma

Table 1 Baseline characteristics of the study sample comprising 178 patients with asthma managed at a university hospital respiratory outpatient clinic

Baseline Characteristics	N (%) or Mean (SD)
Age (yrs.)	47 (16)
Female	136 (76.4%)
ACQ6-score	1.32 (1.07, N = 114)
FeNO	20.3 (18.8, N = 164)
BMI	27.6 (5.8, N = 176)
Allergic Disease	59 (36.7%, N = 164)
GERD	41 (23.0%)
FEV₁ (L)	2.79 L (0.80)
FEV₁%pred	91% (18%)
FVC (L)	3.67 L (1.02, N = 169)
FVC%pred	102% (20, N = 169)
FEV₁/FVC	0.76 (0.09, N = 169)
History of Moderate Exacerbations*	43 (24.2%)
24-month Moderate Exacerbation Rate	1.77 (1.27)
History of Severe Exacerbations**	23 (12.9%)
24-month Severe Exacerbation Rate	1.65 (1.50)
GINA 2020 Asthma Severity Grade
Mild Disease	15 (8.4%)
Moderate Disease	60 (33.7%)
Severe Disease	103 (57.9%)

*defined as either prescription of at least 37.5 mg oral prednisolone for at least 3 days, or hospitalization/emergency room admittance for less than 24 h in the last 24 months prior to inclusion. **defined as any exacerbation requiring hospitalization for at least 24 h and administration of oral or intravenous corticosteroids. N number of patients, yrs. years, ACQ Asthma Control Questionnaire, BMI Body Mass Index, FeNO Fractional Exhaled Nitric Oxide, FEV₁ Forced Expired Volume in the first second, GERD Gastroesophageal Reflux Disease, GINA Global Initiative for Asthma

ISSN: 2054-7064